Relapsed/Refractory Multiple Myeloma Treatment Strategies for Triple-Class Refractory Multiple Myeloma expert roundtables By Ajai Chari, MD; Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO; Robert Z. Orlowski, MD, PhD
Relapsed/Refractory Multiple Myeloma Expert Roundtables Podcast: Salvage Therapy After BCMA-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma expert roundtables By Ajai Chari, MD; Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO; Robert Z. Orlowski, MD, PhD
Relapsed/Refractory Multiple Myeloma Treatment Beyond the Clinical Trial Setting for Relapsed/Refractory Multiple Myeloma clinical topic updates By Ajai Chari, MD
Relapsed/Refractory Multiple Myeloma Later-line Therapies for Relapsed/Refractory Multiple Myeloma clinical topic updates By Ajai Chari, MD
Relapsed/Refractory Multiple Myeloma The Role of Care Partners in Relapsed/Refractory Multiple Myeloma patient care perspectives By Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO